Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 163 Print this page  Email this page Small font size Default font size Increase font size

  Download for Citation Managers



ORIGINAL ARTICLE

Target specific uptake of a newly synthesized radiolabeled 5α-reductase inhibitor “Tc-99m-17-Oxo-17a-Aza-D-Homo-5-Androsten-3β-yl phenoxyacetate (Tc-99m-17a-Aza Steroid)” in rat prostatic neoplastic lesions
Jan Gowsia, Bhat Swati, Chauhan Monika, Dhawan Devinder Kumar, Dhingra Neelima, Chadha Vijayta Dani

Year : 2022 | Volume:  37 | Issue Number:  2 | Page: 133-141



Click here to read this article


Select type of program  for download
EndNote
EndNote format (Mac & Win)
- Download
Reference Manager
Ris format (Win only)
- Download
Procite
Ris format (Win only)
- Download
Medlars Format - Download
RefWorks Format
RefWorks format (Mac & Win)
- Download
BibTex Format
BibTex format (Mac & Win)
- Download
  Feedback 
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal